These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17658958)

  • 41. A multifaceted pharmacist intervention to improve antihypertensive adherence: a cluster-randomized, controlled trial (HAPPy trial).
    Stewart K; George J; Mc Namara KP; Jackson SL; Peterson GM; Bereznicki LR; Gee PR; Hughes JD; Bailey MJ; Hsueh YA; McDowell JM; Bortoletto DA; Lau R
    J Clin Pharm Ther; 2014 Oct; 39(5):527-34. PubMed ID: 24943987
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Patients' Attitudes and Approaches to the Self-Management of Hypertension: Perspectives from an Australian Qualitative Study in Community Pharmacy.
    Bajorek B; Lemay K; Magin P; Roberts C; Krass I; Armour C
    High Blood Press Cardiovasc Prev; 2017 Jun; 24(2):149-155. PubMed ID: 28168358
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Management of hypertension in an Australian community pharmacy setting - patients' beliefs and perspectives.
    Bajorek BV; LeMay KS; Magin PJ; Roberts C; Krass I; Armour CL
    Int J Pharm Pract; 2017 Aug; 25(4):263-273. PubMed ID: 27633151
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lifestyle changes for prehypertension with other cardiovascular risk factors: findings from Thailand.
    Pongwecharak J; Treeranurat T
    J Am Pharm Assoc (2003); 2011; 51(6):719-26. PubMed ID: 22068193
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An evaluation of a community pharmacy-based rural asthma management service.
    Saini B; Filipovska J; Bosnic-Anticevich S; Taylor S; Krass I; Armour C
    Aust J Rural Health; 2008 Apr; 16(2):100-8. PubMed ID: 18318852
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effectiveness of community-based hypertension management on hypertension in the urban slums of Haiti: A mixed methods study.
    St Sauveur R; Sufra R; Jean Pierre MC; Rouzier V; Preval F; Exantus S; Jean M; Jean J; Forestal GP; Fleurijean O; Mourra N; Ogyu A; Malebranche R; Brisma JP; Deschamps MM; Pape JW; Sundararajan R; McNairy ML; Yan LD
    J Clin Hypertens (Greenwich); 2024 Oct; 26(10):1133-1144. PubMed ID: 39150035
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Mississippi Delta Health Collaborative Medication Therapy Management Model: Public Health and Pharmacy Working Together to Improve Population Health in the Mississippi Delta.
    Ross LA; Bloodworth LS; Brown MA; Malinowski SS; Crane R; Sutton V; Karimi M; Dove Brown AC; Dobbs T; Hites L
    Prev Chronic Dis; 2020 Sep; 17():E108. PubMed ID: 32945767
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The impact of a multidisciplinary information technology-supported program on blood pressure control in primary care.
    Rinfret S; Lussier MT; Peirce A; Duhamel F; Cossette S; Lalonde L; Tremblay C; Guertin MC; LeLorier J; Turgeon J; Hamet P;
    Circ Cardiovasc Qual Outcomes; 2009 May; 2(3):170-7. PubMed ID: 20031834
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regional osteoporosis screening, referral, and monitoring program in community pharmacies: findings from Project ImPACT: Osteoporosis.
    Goode JV; Swiger K; Bluml BM
    J Am Pharm Assoc (2003); 2004; 44(2):152-60. PubMed ID: 15098849
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Hispanic Diabetes Management Program: Impact of community pharmacists on clinical outcomes.
    Oyetayo OO; James C; Martinez A; Roberson K; Talbert RL
    J Am Pharm Assoc (2003); 2011; 51(5):623-6. PubMed ID: 21896461
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The 2017 American College of Cardiology/American Heart Association hypertension guideline and opportunities for community pharmacists.
    Dixon DL; Salgado TM; Caldas LM; Van Tassell BW; Sisson EM
    J Am Pharm Assoc (2003); 2018; 58(4):382-386. PubMed ID: 29804824
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacist-led screening program for an inner-city pediatric population.
    Elliott JP; Harrison C; Konopka C; Wood J; Marcotullio N; Lunney P; Skoner D; Gentile D
    J Am Pharm Assoc (2003); 2015; 55(4):413-8. PubMed ID: 26117001
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of chronic disease management algorithms in Australian community pharmacies.
    Morrissey H; Ball P; Jackson D; Pilloto L; Nielsen S
    Res Social Adm Pharm; 2015; 11(2):176-96. PubMed ID: 25035062
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of a Community Health Worker-Led Multicomponent Intervention on Blood Pressure Control in Low-Income Patients in Argentina: A Randomized Clinical Trial.
    He J; Irazola V; Mills KT; Poggio R; Beratarrechea A; Dolan J; Chen CS; Gibbons L; Krousel-Wood M; Bazzano LA; Nejamis A; Gulayin P; Santero M; Augustovski F; Chen J; Rubinstein A;
    JAMA; 2017 Sep; 318(11):1016-1025. PubMed ID: 28975305
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of a pharmacist-managed hypertension program on health system costs: an evaluation of the Study of Cardiovascular Risk Intervention by Pharmacists-Hypertension (SCRIP-HTN).
    Houle SK; Chuck AW; McAlister FA; Tsuyuki RT
    Pharmacotherapy; 2012 Jun; 32(6):527-37. PubMed ID: 22552863
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of pharmacist care for hypertension in the Veterans Affairs patient-centered medical home: a retrospective case-control study.
    Zillich AJ; Jaynes HA; Bex SD; Boldt AS; Walston CM; Ramsey DC; Sutherland JM; Bravata DM
    Am J Med; 2015 May; 128(5):539.e1-6. PubMed ID: 25534422
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Patient outcomes following an intervention involving community pharmacists in the management of depression.
    Crockett J; Taylor S; Grabham A; Stanford P
    Aust J Rural Health; 2006 Dec; 14(6):263-9. PubMed ID: 17121506
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of Pharmacists' Work in a Physician-Pharmacist Collaborative Model for the Management of Hypertension.
    Isetts BJ; Buffington DE; Carter BL; Smith M; Polgreen LA; James PA
    Pharmacotherapy; 2016 Apr; 36(4):374-84. PubMed ID: 26893135
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey.
    Wibowo Y; Parsons R; Sunderland B; Hughes J
    Int J Clin Pharm; 2015 Oct; 37(5):873-82. PubMed ID: 25986291
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Self-monitoring and other non-pharmacological interventions to improve the management of hypertension in primary care: a systematic review.
    Glynn LG; Murphy AW; Smith SM; Schroeder K; Fahey T
    Br J Gen Pract; 2010 Dec; 60(581):e476-88. PubMed ID: 21144192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.